Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
Clinical trial NCT05819398 · COMPLETED
Trial details
- NCT number
- NCT05819398
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2024-08-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.